Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Brand Name :
No Data Available.
Synonyms :
meloxicam
Class :
Anti-inflammatory drugs and non-steroidal anti-inflammatory drugs (NSAIDs)
Dosage Forms & Strengths
Capsule, Oral:
5 mg
10 mg
Injectable, Intravenous:
30 mg/ml (1ml)
Suspension, Oral:
7.5 mg/5ml (100 ml)
Tablet, Oral:
7.5 mg
15 mg
Tablet disintegrating, Oral:
7.5 mg
15 mg
Note: Lowest effective dose should be administered; administration is recommended in combination with proton pump inhibitor in patients with existing or at risk of cardiovascular disease, GI disease, kidney impairment, and chronic liver disease
Do not change the dosage form and strength prescribed by your doctor
No safe and efficacious dosing instructions were found.
Refer to adult dosing
Note: For higher doses in patients >60 years of age: Dual antiplatelet or an anticoagulant is recommended.
may increase the risk or severity of methemoglobinemia when miltefosine is combined
interaction with NSAIDs may lead to increased toxicity such as myelosuppression, renal toxicity, and GI toxicity
interaction with NSAIDs may lead to increased toxicity such as myelosuppression, renal toxicity, and GI toxicity
may enhance the serum concentration of CYP2C19 Inhibitors
may enhance the serum concentration of CYP2C19 Inhibitors
It may enhance the toxicity when combined with mipomersen
Combining meloxicam with pranlukast may cause a reduction in the meloxicam’s metabolism
When meloxicam is used together with sertraline, the risk or seriousness of bleeding may be enhanced
When cyclacillin is used together with meloxicam, this leads to increased risk or seriousness of methemoglobinemia
When meloxicam is used together with bufexamac, this leads to enhanced risk or seriousness of adverse outcomes
when aclarubicin is combined with meloxicam, there is an increased risk of methemoglobinemia
meloxicam leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
When meloxicam is used together with nifenazone, this leads to enhanced risk or seriousness of adverse events
When meloxicam is used together with diazoxide, this leads to reduction in therapeutic effectiveness of diazoxide
when both drugs are combined, the risk or severity of adverse effects increases
when combined may increase anticoagulation
when combined may increase anticoagulation
may increase the anticoagulation effect when combined
the risk of methemoglobinemia may be increased
the risk of methemoglobinemia can be increased
when both drugs are combined, there may be an increased effect of meloxicam by acidic (anionic) drug competition for renal tubular clearance
sulfamethoxazole increases the effect of meloxicam by altering hepatic CYP2C9/10 enzyme metabolism
Significant considerations:
Acute myocardial infarction
Cerebrovascular accident
Heart failure
Frequency defined:
>10%
Edema
Increased liver enzymes
Abdominal pain
Dyspepsia
Flatulence
Gastrointestinal bleeding
Nausea
vomiting
Tremor
Weakness
Visual disturbance
Amnesia
Anxiety
Drowsiness
Headache
Anxiety
Insomnia
Malaise
Nervousness
Skin rash
<1% postmarketing:
Altered sense of smell
Anemia
Cardiac failure
Cerebra; ischemia
Confusion
Cardiac failure
Epistaxis
Hepatitis
Hepatotoxicity
Stomatitis
Urticaria
Vasodilation
Necrolysis
Peptic ulcer
Pregnancy consideration: Some studies reported the risk of miscarriage associated with NSAIDs
Lactation: meloxicam can be excreted in breast milk. The lowest possible dose is recommended for lactating females.
Pregnancy category:
Patient information leaflet
Generic Name: Meloxicam
Pronounced: meloxicam
Why do we use meloxicam?
Meloxicam is used to treat different types of arthritis. It is used to ease the pain. It can be prescribed by your doctor for many other reasons.